17 human cohorts from around Europe
HEDIMED
Read More
European Exposome Network
HEDIMED
The HEDIMED project aims to identify the environmental causes behind type 1 diabetes, celiac disease, allergies and asthma.
18 cohorts from over 9 countries
Learn more
European Exposome Network
The HEDIMED Mission
The mission of HEDIMED is to find out prevention for immune-mediated diseases, including type 1 diabetes, celiac disease, asthma and allergies. This will be accomplished by identifying the environmental exposures contributing to the development of these diseases.
HEDIMED Partners
Previous
Next
Get to know our partners
Research
HEDIMED brings together data and biological samples from 17 human cohorts. These cohorts come from high and low-risk countries of immune-mediated diseases. The project consists of 13 work packages that will generate new knowledge about the causes of these diseases by exploring the role of the environment, using the latest technologies developed by the 22 partners.
HEDIMED project complies with international conventions and codes of conduct in its research activities, and EU regulations, including GDPR, will be followed in the consortium.
Cohorts
Read more
Work Packages
Read more
Ethics
Read more
The European Exposome Network
The European Human Exposome Network is the world’s largest network consisting of nine projects studying the impact of environmental exposure on human health, funded by the European Union.
News
May 5, 2020
Hedimed Kickoff
In February 2020 the entire HEDIMED consortium gathered together for the first time in a three-day kick-off meeting in Tampere Hall, Tampere, Finland. In a…
May 3, 2020
EHEN NETWORK LAUNCH
11th of February 2020 The nine projects of the European Human Exposome Network had a common launching event on February 10th in Brussels. The event…